|
|
If "no" is selected, indicate reasons for not providing services by placing an "X" in corresponding cells (select all that apply). Leave corresponding cells empty if "yes" is selected in Column C. |
|
Laboratory Recommendation |
Does your clinic provide this service? |
Insufficient resources (funding, lack of culture plates and inability to incubate them) |
Insufficient staffing (capacity, qualifications, training) |
Population served |
Protocols and procedures (procedures don’t allow for collection) |
Referral process in place |
Other, please specify |
At the time of patient visit: pH paper |
|
|
|
|
|
|
|
At the time of patient visit: Thermometer |
|
|
|
|
|
|
|
At time of patient visit: Dark field microscopy for syphilis |
|
|
|
|
|
|
|
At time of patient visit: Gram stain, methylene blue, or gentian violet stain for urethritis |
|
|
|
|
|
|
|
At time of patient visit: On-site qualitative non-treponemal serologic test for syphilis |
|
|
|
|
|
|
|
At time of patient visit: Phlebotomy |
|
|
|
|
|
|
|
At time of patient visit: Test for bacterial vaginosis |
|
|
|
|
|
|
|
At time of patient visit: Test for HIV |
|
|
|
|
|
|
|
At time of patient visit: Test for pregnancy |
|
|
|
|
|
|
|
At time of patient visit: Test for trichomoniasis |
|
|
|
|
|
|
|
At time of patient visit: Test for vulvovaginal candidiasis |
|
|
|
|
|
|
|
At time of patient visit: Urinalysis with microscopy |
|
|
|
|
|
|
|
At time of patient visit: Urine dipstick |
|
|
|
|
|
|
|
Through clinical laboratory: Extragenital (pharynx and rectum) NAAT for gonorrhea and chlamydia |
|
|
|
|
|
|
|
Through clinical laboratory: Fourth generation antigen/antibody HIV test |
|
|
|
|
|
|
|
Through clinical laboratory: Gonorrhea antimicrobial susceptibility testing |
|
|
|
|
|
|
|
Through clinical laboratory: Gonorrhea culture |
|
|
|
|
|
|
|
Through clinical laboratory: Gram stain, methylene blue, or gentian violet stain for urethritis |
|
|
|
|
|
|
|
Through clinical laboratory: HSV serology |
|
|
|
|
|
|
|
Through clinical laboratory: HSV viral culture or PCR |
|
|
|
|
|
|
|
Through clinical laboratory: NAAT for trichomoniasis |
|
|
|
|
|
|
|
Through clinical laboratory: Laboratory tests needed for providing nPEP and PrEP, as per clinical protocol |
|
|
|
|
|
|
|
Through clinical laboratory: Oncogenic HPV NAATs with Pap smear |
|
|
|
|
|
|
|
Through clinical laboratory: Quantitative nontreponemal serologic test for syphilis |
|
|
|
|
|
|
|
Through clinical laboratory: Serologic tests for hepatitis A |
|
|
|
|
|
|
|
Through clinical laboratory: Serologic tests for hepatitis B |
|
|
|
|
|
|
|
Through clinical laboratory: Serologic tests for hepatitis C |
|
|
|
|
|
|
|
Through clinical laboratory: Test for pregnancy |
|
|
|
|
|
|
|
Through clinical laboratory: Treponemal serologic test for syphilis |
|
|
|
|
|
|
|
Through clinical laboratory: Urogenital NAAT for gonorrhea and chlamydia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jump to: |
|
|
|
|
|
|
|
Instructions sheet |
|
|
|
|
|
|
|
Assessment Summary sheet |
|
|
|
|
|
|
|
Additional Information sheet |
|
|
|
|
|
|
|
Quality STD Services Summary Table (% of recommendations met) |
|
|
|
|
|
Recommendations |
Primary Care/Should |
Primary Care/Could |
Specialized/Should |
Specialized/Could |
|
|
|
|
|
Prevention |
0% |
0% |
0% |
0% |
|
|
|
|
|
Evaluation of STD-Related Conditions |
0% |
|
0% |
|
|
|
|
|
|
Laboratory |
0% |
0% |
0% |
0% |
|
|
|
|
|
Treatment |
0% |
0% |
0% |
0% |
|
|
|
|
|
Sexual History & Exam |
0% |
0% |
0% |
0% |
|
|
|
|
|
Screening |
0% |
0% |
0% |
0% |
|
|
|
|
|
Partner Services |
0% |
0% |
0% |
|
|
|
|
|
|
Total % of all recommendations met |
0% |
0% |
0% |
0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prevention Recommendation |
Does your clinic provide this service? |
Insufficient resources (funding, equipment, no lab or dispensing on premises) |
Insufficient staffing (capacity, qualifications, training) |
Population served |
Protocols and procedures (lack of protocol or standing orders) |
Referral process in place |
Legal and cultural barriers (minor consent, conservative environment) |
Limited referral network for treatment |
Other, please specify |
On-site hepatitis B vaccination or referral |
|
|
|
|
|
|
|
|
|
On-site HPV vaccination or referral |
|
|
|
|
|
|
|
|
|
On-site hepatitis A vaccination |
|
|
|
|
|
|
|
|
|
On-site condom provision |
No |
X |
|
|
|
|
|
|
|
Brief single STD/HIV prevention counseling session (up to 30 minutes) |
|
|
|
|
|
|
|
|
|
Moderate-intensity STD behavioral counseling (≥30 minutes) |
|
|
|
|
|
|
|
|
|
High-Intensity STD behavioral counseling (≥2 hours) |
|
|
|
|
|
|
|
|
|
Brief contraceptive counseling or referral |
|
|
|
|
|
|
|
|
|
Emergency contraceptive pills |
|
|
|
|
|
|
|
|
|
Risk assessment, education and referral or link to HIV care for pre-exposure prophylaxis (PrEP) for HIV prevention |
|
|
|
|
|
|
|
|
|
Risk assessment, education and referral or link to HIV care for non-occupational post-exposure prophylaxis (nPEP) |
|
|
|
|
|
|
|
|
|
Provision of PrEP for HIV prevention |
|
|
|
|
|
|
|
|
|
Provision of nPEP of HIV |
|
|
|
|
|
|
|
|
|
Referral or link to HIV care, if indicated |
|
|
|
|
|
|
|
|
|
Referral or link to family planning services, if indicated |
|
|
|
|
|
|
|
|
|
Referral or link to behavioral health services, if indicated |
|
|
|
|
|
|
|
|
|
|
Reasons not met (%) |
100% |
0% |
0% |
0% |
0% |
0% |
0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Evaluation of STD-Related Conditions Recommendation |
Does your clinic provide this service? |
Insufficient resources (funding, equipment) |
Insufficient staffing (capacity, qualifications, training) |
Population served |
Protocols and procedures (express visit protocol, unclear guidelines) |
Referral process in place |
Other |
|
|
Evaluation (history and examination) for Genital ulcer disease |
|
|
|
|
|
|
|
|
|
Evaluation (history and examination) for Male urethritis syndrome |
|
|
|
|
|
|
|
|
|
Evaluation (history and examination) for Vaginal discharge |
|
|
|
|
|
|
|
|
|
Evaluation (history and examination) for pelvic inflammatory disease (PID) |
|
|
|
|
|
|
|
|
|
Evaluation (history and examination) for Genital warts |
|
|
|
|
|
|
|
|
|
Evaluation (history and examination) for Proctitis |
|
|
|
|
|
|
|
|
|
Evaluation (history and examination) for Ectoparasitic infections |
|
|
|
|
|
|
|
|
|
Evaluation (history and examination) for Pharyngitis |
|
|
|
|
|
|
|
|
|
Evaluation (history and examination) for Epididymitis |
|
|
|
|
|
|
|
|
|
Evaluation (history and examination) for Systemic or dermatologic conditions compatible with or suggestive of an STD etiology |
|
|
|
|
|
|
|
|
|
|
Reasons not met (%) |
#DIV/0! |
#DIV/0! |
#DIV/0! |
#DIV/0! |
#DIV/0! |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Laboratory Recommendation |
Does your clinic provide this service? |
Insufficient resources (funding, lack of culture plates and inability to incubate them) |
Insufficient staffing (capacity, qualifications, training) |
Population served |
Protocols and procedures (procedures don’t allow for collection) |
Referral process in place |
Other, please specify |
|
|
At the time of patient visit: pH paper |
|
|
|
|
|
|
|
|
|
At the time of patient visit: Thermometer |
|
|
|
|
|
|
|
|
|
At time of patient visit: Dark field microscopy for syphilis |
|
|
|
|
|
|
|
|
|
At time of patient visit: Gram stain, methylene blue, or gentian violet stain for urethritis |
|
|
|
|
|
|
|
|
|
At time of patient visit: On-site qualitative non-treponemal serologic test for syphilis |
|
|
|
|
|
|
|
|
|
At time of patient visit: Phlebotomy |
|
|
|
|
|
|
|
|
|
At time of patient visit: Test for bacterial vaginosis |
|
|
|
|
|
|
|
|
|
At time of patient visit: Test for HIV |
|
|
|
|
|
|
|
|
|
At time of patient visit: Test for pregnancy |
|
|
|
|
|
|
|
|
|
At time of patient visit: Test for trichomoniasis |
|
|
|
|
|
|
|
|
|
At time of patient visit: Test for vulvovaginal candidiasis |
|
|
|
|
|
|
|
|
|
At time of patient visit: Urinalysis with microscopy |
|
|
|
|
|
|
|
|
|
At time of patient visit: Urine dipstick |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Extragenital (pharynx and rectum) NAAT for gonorrhea and chlamydia |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Fourth generation antigen/antibody HIV test |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Gonorrhea antimicrobial susceptibility testing |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Gonorrhea culture |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Gram stain, methylene blue, or gentian violet stain for urethritis |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: HSV serology |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: HSV viral culture or PCR |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: NAAT for trichomoniasis |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Laboratory tests needed for providing nPEP and PrEP, as per clinical protocol |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Oncogenic HPV NAATs with Pap smear |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Quantitative nontreponemal serologic test for syphilis |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Serologic tests for hepatitis A |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Serologic tests for hepatitis B |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Serologic tests for hepatitis C |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Test for pregnancy |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Treponemal serologic test for syphilis |
|
|
|
|
|
|
|
|
|
Through clinical laboratory: Urogenital NAAT for gonorrhea and chlamydia |
|
|
|
|
|
|
|
|
|
|
Reasons not met (%) |
#DIV/0! |
#DIV/0! |
#DIV/0! |
#DIV/0! |
#DIV/0! |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Treatment Recommendation |
Does your clinic provide this service on site? |
Insufficient resources (cost, procurement, don’t stock due to infrequent use) |
Insufficient staffing (capacity, training, qualifications) |
Population served |
Protocols and procedures (prescription given if medicine not available on site) |
Referral process in place |
Other, please specify |
|
|
On site: treatment for gonorrhea |
|
|
|
|
|
|
|
|
|
On site: treatment for chlamydia |
|
|
|
|
|
|
|
|
|
On site: treatment for cervicitis |
|
|
|
|
|
|
|
|
|
On site: treatment for nongonococcal urethritis |
|
|
|
|
|
|
|
|
|
On site: treatment for proctitis |
|
|
|
|
|
|
|
|
|
On site: treatment for PID |
|
|
|
|
|
|
|
|
|
On site: treatment for epididymitis |
|
|
|
|
|
|
|
|
|
On site: treatment for syphilis |
|
|
|
|
|
|
|
|
|
On site: PrEP |
|
|
|
|
|
|
|
|
|
On site: nPEP |
|
|
|
|
|
|
|
|
|
On site: provider-applied regimens for genital warts |
|
|
|
|
|
|
|
|
|
On site: emergency contraceptive pills |
|
|
|
|
|
|
|
|
|
On site: treatment for trichomoniasis |
|
|
|
|
|
|
|
|
|
On site: treatment for herpes |
|
|
|
|
|
|
|
|
|
On site: treatment for bacterial vaginosis |
|
|
|
|
|
|
|
|
|
On site: treatment for acute or new diagnosis of HIV care |
|
|
|
|
|
|
|
|
|
On site: treatment for persistent and recurrent cervicitis and nongonococcal urethritis |
|
|
|
|
|
|
|
|
|
On site: EPT for gonorrhea and chlamydia |
|
|
|
|
|
|
|
|
|
By prescription: treatment for herpes |
|
|
|
|
|
|
|
|
|
By prescription: treatment for trichomoniasis |
|
|
|
|
|
|
|
|
|
By prescription: treatment for bacterial vaginosis |
|
|
|
|
|
|
|
|
|
By prescription: treatment for vulvovaginal candidiasis |
|
|
|
|
|
|
|
|
|
By prescription: treatment for UTI |
|
|
|
|
|
|
|
|
|
By prescription: PrEP |
|
|
|
|
|
|
|
|
|
By prescription: nPEP |
|
|
|
|
|
|
|
|
|
By prescription: emergency contraceptive pills |
|
|
|
|
|
|
|
|
|
By prescription: patient-applied regimens for genital warts |
|
|
|
|
|
|
|
|
|
By prescription: treatment for ectoparasitic infections |
|
|
|
|
|
|
|
|
|
By prescription: EPT for gonorrhea and chlamydia (EPT for gonorrhea and chlamydia, either on-site OR via prescription, is also included in the Partner Services section) |
|
|
|
|
|
|
|
|
|
|
Reasons not met (%) |
#DIV/0! |
#DIV/0! |
#DIV/0! |
#DIV/0! |
#DIV/0! |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sexual History and Physical Exam Recommendation |
Does your clinic provide this service? |
Insufficient resources (funding, equipment) |
Insufficient staffing (capacity, training, provider discomfort) |
Population served (patient need, reluctance) |
Protocols and procedures (5 Ps, express visit protocol, EMR/EHR prompts) |
Referral process in place |
Other, please specify |
|
|
A sexual history and risk assessment as part of initial comprehensive or annual visit |
|
|
|
|
|
|
|
|
|
A sexual history and risk assessment at each visit concerning reproductive, genital, or urological issues |
|
|
|
|
|
|
|
|
|
A sexual history and risk assessment at each visit unrelated to reproductive, genital, or urologic concerns |
|
|
|
|
|
|
|
|
|
A sexual history and risk assessment at every visit for patients with STD-related symptoms, STD-related concerns, or concerns about preventing or achieving pregnancy |
|
|
|
|
|
|
|
|
|
A physical examination for male and female patients with STD-related symptoms, STD-related concerns, or those at high behavioral risk for incident STDs |
|
|
|
|
|
|
|
|
|
A pelvic examination |
|
|
|
|
|
|
|
|
|
Colposcopy for female patients with abnormal Pap smears |
|
|
|
|
|
|
|
|
|
Anoscopy |
|
|
|
|
|
|
|
|
|
A high-resolution anoscopy for patients with abnormal anal Pap smears |
|
|
|
|
|
|
|
|
|
|
Reasons not met (%) |
#DIV/0! |
#DIV/0! |
#DIV/0! |
#DIV/0! |
#DIV/0! |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Screening Recommendation |
Does your clinic provide this service? |
Insufficient resources (funding, equipment, test not available) |
Insufficient staffing (capacity to follow up on abnormal results) |
Population served |
Limited referral network for treatment |
Other, please specify |
|
|
|
Gonorrhea screening |
|
|
|
|
|
|
|
|
|
Chlamydia screening |
|
|
|
|
|
|
|
|
|
Syphilis screening |
|
|
|
|
|
|
|
|
|
Hepatitis B screening |
|
|
|
|
|
|
|
|
|
Hepatitis C screening |
|
|
|
|
|
|
|
|
|
HIV screening |
|
|
|
|
|
|
|
|
|
Cervical cancer screening |
|
|
|
|
|
|
|
|
|
Trichomoniasis screening |
|
|
|
|
|
|
|
|
|
Anal cancer screening |
|
|
|
|
|
|
|
|
|
|
Reasons not met (%) |
#DIV/0! |
#DIV/0! |
#DIV/0! |
#DIV/0! |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Partner Services Recommendation |
Does your clinic provide this service? |
Insufficient resources (funding, equipment, cost to patient) |
Insufficient staffing (staff discomfort, capacity, training) |
Protocols and procedures (e-prescribing issues, provide refill to original patient instead, no DIS referral) |
Legal and cultural barriers (EPT not legal, staff/leadership opposition) |
Other, please specify |
|
|
|
Guidance regarding notification and care of sex partners |
|
|
|
|
|
|
|
|
|
EPT (where legal and where local or state jurisdictions do not prohibit by regulation) |
|
|
|
|
|
|
|
|
|
Interactive counseling for partner notification |
|
|
|
|
|
|
|
|
|
Health department disease intervention specialist (DIS) elicitation of sex partner information to identify those who might have been exposed and to identify patient follow-up needs |
|
|
|
|
|
|
|
|
|
|
Reasons not met (%) |
#DIV/0! |
#DIV/0! |
#DIV/0! |
#DIV/0! |
|
|
|
|
Jump to: |
Prevention sheet |
Evaluation of STD-Related Conditions sheet |
Laboratory sheet |
Treatment sheet |
Sexual History & Exam sheet |
Screening sheet |
Partner Services sheet |
Assessment Summary sheet |
Instructions sheet |
|
|
|
|
|
|
|
|
|
|
|
|
Recommendation |
Additional Information |
PREVENTION |
Brief single STD/HIV prevention counseling session (up to 30 minutes) |
Brief prevention counseling is conducted in a single session using strategies, such as motivational interviewing and building rapport, and includes patient circumstances and needs in the counseling plan. Moderate-intensity and high-intensity behavioral counseling is contact time of 30–120 minutes and ≥2 hours, respectively. |
Moderate-intensity STD behavioral counseling (≥30 minutes) |
Brief prevention counseling is conducted in a single session using strategies, such as motivational interviewing and building rapport, and includes patient circumstances and needs in the counseling plan. Moderate-intensity and high-intensity behavioral counseling is contact time of 30–120 minutes and ≥2 hours, respectively. |
High-intensity STD behavioral counseling (≥2 hours) |
Brief prevention counseling is conducted in a single session using strategies, such as motivational interviewing and building rapport, and includes patient circumstances and needs in the counseling plan. Moderate-intensity and high-intensity behavioral counseling is contact time of 30–120 minutes and ≥2 hours, respectively. |
Risk assessment, education and referral or link to HIV care for pre-exposure prophylaxis (PrEP) for HIV prevention |
Provided by a clinician or other appropriately trained staff. |
Risk assessment, education and referral or link to HIV care for non-occupational post-exposure prophylaxis (nPEP) |
Provided by a clinician or other appropriately trained staff. |
Emergency contraceptive pills |
If emergency contraceptive pills are not available on site or by prescription, patients can be advised that levonorgestrel emergency contraceptive pills are available over the counter and ulipristal acetate emergency contraceptive pills are only available by prescription. Emergency contraceptive pills should be taken as soon as possible within 5 days of unprotected sex. |
On-site condom provision |
Providers can partner with local organizations, such as the local health department and community-based organizations, to procure condoms. In some states, prescriptions can be written for condoms. For certain settings, such as family planning clinics, condoms should be available on-site. |
Provision of PrEP for HIV prevention |
Basic STD Care: PrEP could be available by starter packs or prescription with on-site follow-up care for basic STD care. If PrEP is not provided, navigator-assisted referral for PrEP should be provided with first appointment made while the patient is on site.
Specialized STD Care: PrEP should be available in starter packs or by prescription with on-site follow-up care for specialized STD care. If PrEP is not provided, navigator-assisted referral for PrEP should be provided with first appointment made while the patient is on site. |
Provision of nPEP of HIV |
Basic STD Care: nPEP starter pack (3–7 days of medication) could be available on site, with either on-site follow-up care or referral for basic STD care. nPEP starter pack or complete 28-day course could be available by prescription, with either on-site follow-up care or referral, with first appointment made while the patient is on site. Provision of the complete 28-day nPEP medication supply at the initial visit rather than a starter pack of 3–7 days has been reported to increase likelihood of adherence, especially when patients find returning for multiple follow-up visits difficult. Routinely providing starter packs or the complete 28-day course requires that health care providers stock nPEP drugs in their practice setting or have an established agreement with a pharmacy to stock, package, and urgently dispense nPEP drugs with required administration instructions (https://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdfpdf icon).
Specialized STD Care: nPEP starter pack (3–7 days of medication) should be available on site, with either on-site follow-up care or referral to specialized STD care. nPEP complete 28-day course should be available by prescription, with either on-site follow-up care or referral, with first appointment made while the patient is on site. Provision of the complete 28-day nPEP medication supply at the initial visit rather than a starter pack of 3–7 days has been reported to increase likelihood of adherence, especially when patients find returning for multiple follow-up visits difficult. |
EVALUATION |
Proctitis |
Evaluation for proctitis might include visual examination of the anus, anorectal examination with a rectal swab, digital anorectal exam, or anoscopy. For specialized STD care, high-resolution anoscopy might be included. |
LABORATORY |
At the time of patient visit |
"At the time of patient visit" refers to providing a service the same day of the patient encounter. The intent is for a patient to receive test results prior to the conclusion of a clinic visit to ensure same day diagnosis and initiation of treatment as needed. |
Test for trichomoniasis |
On-site test for trichomoniasis can include wet mount microscopy and OSOM® Trichomonas. |
Test for bacterial vaginosis |
On-site test for bacterial vaginosis can include wet mount microscopy, OSOM® BVBlue®, and Affirm™. |
Test for vulvovaginal candidiasis |
On-site test for vulvovaginal candidiasis can include wet mount microscopy. |
Gonorrhea antimicrobial susceptibility testing |
Access needs to be established for transport medium that adequately maintains the viability of Neisseria gonorrhoeae until the specimen reaches a laboratory (e.g., transport medium in transport container, transport system, or transport swab). Providers should contact their state or local health department if they have concerns about resistant N. gonorrhoeae infection or if assistance is required for culture and antimicrobial susceptibility testing. |
TREATMENT |
Gonorrhea |
Providers might not receive reimbursement for oral medications without an on-site pharmacy. Providers can partner with local organizations, such as the local health department and community-based organizations, to procure oral medications or refer patients to local organizations. |
Chlamydia |
Providers might not receive reimbursement for oral medications without an on-site pharmacy. Providers can partner with local organizations, such as the local health department and community-based organizations, to procure oral medications or refer patients to local organizations. |
Nongonococcal urethritis |
Providers might not receive reimbursement for oral medications without an on-site pharmacy. Providers can partner with local organizations, such as the local health department and community-based organizations, to procure oral medications or refer patients to local organizations. |
Syphilis |
Providers can partner with local health departments to procure injectable benzathine penicillin G or refer patients to local health department and verify treatment. |
Emergency contraceptive pills |
If emergency contraceptive pills are not available on site or by prescription, patients can be advised that levonorgestrel emergency contraceptive pills are available over the counter and ulipristal acetate emergency contraceptive pills are only available by prescription. Emergency contraceptive pills should be taken as soon as possible within 5 days of unprotected sex. |
EPT for gonorrhea and chlamydia |
Information on the legal status of EPT for each state is available at https://www.cdc.gov/std/ept/legal/default.htm. |
PARTNER SERVICES |
Partner services |
Partner services consist of various strategies with differing levels of time and effort to enable persons who are exposed to an STD to be identified, tested, and treated. (Refer to the 'Partner Services' section of the Recommendations for additional information.) |
Guidance regarding notification and care of sex partners |
Guidance regarding notification and care of sex partners is described as providers giving how-to information to their patients about the need to notify their sex partner(s) of the exposure, the need for sex partner(s) to seek care and treatment even if they do not have symptoms, and where partner(s) could go for STD care. (Refer to the 'Partner Services' section of the Recommendations for additional information.) |
EPT (where legal and where local or state jurisdictions do not prohibit by regulation) |
Expedited Partner Therapy (EPT), also termed patient-delivered partner therapy (PDPT), is the clinical practice of treating the sex partner(s) of persons who receive chlamydia or gonorrhea diagnoses by providing medications or prescriptions to the patient. Patients then provide partner(s) with these therapies without the health care provider having examined the partner(s) (see www.cdc.gov/std/ept).
Information on legal status of EPT for each state is available at http://www.cdc.gov/std/ept/legal/default.htm. |
Interactive counseling for partner notification |
In interactive counseling, the provider and patient both actively participate in an individualized plan to notify the patient’s sex partner(s). Interactive counseling typically is conducted by staff with specific training or skills in communication, interviewing, or counseling. The patient provides information about their sex partner(s) and develops a plan with the counselor to notify partner(s). |
DIS |
A disease intervention specialist (DIS) is a public health professional with applied expertise in client-centered interviews; partner services that include contact tracing, directly observed therapy, field specimen collection, and field investigation in outbreaks; and navigation of health care systems to ensure patient evaluation and treatment, among other areas. (Refer to the 'Partner Services' section of the Recommendations for additional information.) |
Health department DIS elicitation of sex partner information to identify those who might have been exposed and to identify patient follow-up needs |
Partner services can be provided on site or by referral. |